330889770	330889770	CD	B-NP	O
|	|	VBG	I-NP	O
AM	AM	NN	I-NP	O
|	|	JJ	I-NP	O
57771309	57771309	CD	I-NP	O
|	|	NN	I-NP	O
0046663	0046663	CD	B-NP	O
|	|	CC	I-NP	O
10/12/2005	10/12/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
bleeding	bleed	VBG	I-NP	O
AV-fistula	AV-fistula	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/11/2005	10/11/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/10/2005	9/10/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
ROARTY	ROARTY	NNP	B-NP	O
,	,	,	O	O
DESMOND	DESMOND	NNP	B-NP	O
BEN	BEN	NNP	I-NP	O
859-62-12-4	859-62-12-4	CD	I-NP	O
Oportvall	Oportvall	NNP	I-NP	O
Ry	Ry	NNP	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
Relah	Relah	NNP	B-NP	O
Drive	Drive	NNP	I-NP	O
,	,	,	O	O
Kee	Kee	NNP	B-NP	O
,	,	,	O	O
Ohio	Ohio	NNP	B-NP	O
44488	44488	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
RNM	RNM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/21/05	10/21/05	CD	B-NP	O
AT	AT	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CHRYSTAL	CHRYSTAL	NNP	B-NP	O
,	,	,	O	O
CHI	CHI	NNP	B-NP	O
DUNCAN	DUNCAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Skilled	Skille	VBN	B-VP	O
Nursing	Nurse	VBG	B-VP	O
Facility	Facility	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CHILDREN	CHILDREN	NNP	I-NP	O
'S	'S	POS	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
CEPACOL	CEPACOL	NN	I-NP	O
1-2	1-2	CD	I-NP	O
LOZENGE	LOZENGE	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
sore	sore	NN	B-NP	O
throat	throat	IN	B-PP	O
FOLIC	FOLIC	NN	B-NP	B-protein
ACID	ACID	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HYDRALAZINE	HYDRALAZINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ISORDIL	ISORDIL	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
LOPRESSOR	LOPRESSOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NYSTATIN	NYSTATIN	NN	B-NP	B-protein
SUSPENSION	SUSPENSION	NN	I-NP	I-protein
5	5	CD	B-NP	I-protein
MILLILITERS	MILLILITERS	NNS	I-NP	I-protein
PO	PO	NNP	B-NP	I-protein
QID	QID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
swish	swish	VB	B-VP	O
and	and	CC	I-VP	O
swallow	swallow	VB	I-VP	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/1/05	1/1/05	CD	B-NP	O
by	by	IN	B-PP	O
SARKA	SARKA	NNP	B-NP	O
,	,	,	O	O
JACQUES	JACQUES	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NEPHROCAPS	NEPHROCAPS	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
94241664	94241664	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

MAALOX/BEN/LIDO	MAALOX/BEN/LIDO	NN	B-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
15	15	CD	I-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
SWISH	SWISH	NNP	I-NP	O
&	&	CC	I-NP	O
SWALLOW	SWALLOW	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
for	for	IN	B-PP	O
sore	sore	NN	B-NP	O
throat	throat	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
may	may	MD	B-VP	O
refuse	refuse	VB	I-VP	O
.	.	.	O	O

NEPHROCAPS	NEPHROCAPS	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	O
RX	RX	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/1/05	1/1/05	CD	B-NP	O
by	by	IN	B-PP	O
HOLLINSHED	HOLLINSHED	NNP	B-NP	O
,	,	,	O	O
SAMMIE	SAMMIE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/14	2/14	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
if	if	IN	B-SBAR	O
patient	patient	NN	B-NP	O
starts	start	VBZ	B-VP	O
to	to	TO	I-VP	O
bleed	bleed	VB	I-VP	O
from	from	IN	B-PP	O
fistula	fistula	NN	B-NP	O
site	site	NN	I-NP	O
KEPPRA	KEPPRA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LEVETIRACETAM	LEVETIRACETAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6	6	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/24	4/24	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
1	1	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	O
QUICK	QUICK	NNP	I-NP	O
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
TAB	TAB	NNP	I-NP	O
PO	PO	NNP	I-NP	O
x1	x1	NN	I-NP	O
PRN	PRN	NNP	I-NP	O
Upset	Upset	NNP	I-NP	O
Stomach	Stomach	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Partial	Partial	JJ	B-NP	O
weight-bearing	weight-bearing	NN	I-NP	O
:	:	:	O	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

Full	Full	JJ	B-NP	O
weight-bearing	weight-bearing	NN	I-NP	O
:	:	:	O	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Diabetes	Diabetes	NN	B-NP	O
clinic	clinic	NN	I-NP	O
with	with	IN	B-PP	O
dr	dr	NN	B-NP	O
Omer	Omer	NNP	I-NP	O
Ondersma	Ondersma	NNP	I-NP	O
11/18/05	11/18/05	CD	I-NP	O
8AM	8AM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Cardiology/arrhythmia	Cardiology/arrhythmia	NN	B-NP	O
with	with	IN	B-PP	O
dr	dr	NN	B-NP	O
Elliott	Elliott	NNP	I-NP	O
Kaveney	Kaveney	NNP	I-NP	O
11/18/05	11/18/05	CD	I-NP	O
2PM	2PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
TETRACYCLINE	TETRACYCLINE	NN	B-NP	O
ANALOGUES	ANALOGUES	VBZ	B-VP	O
ADMIT	ADMIT	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
bleeding	bleed	VBG	B-VP	O
AV-fistula	AV-fistula	NNP	B-NP	O
,	,	,	O	O
ROMI	ROMI	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
bleeding	bleed	VBG	B-VP	O
AV-fistula	AV-fistula	NNP	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
ESRD	ESRD	NNP	I-NP	O
IDDM-hypo/hyperglycemic	IDDM-hypo/hyperglycemic	JJ	I-NP	O
seizures	seizure	NNS	I-NP	O
s/p	s/p	VBP	B-VP	O
AV	AV	NN	B-NP	O
fistula	fistula	NN	I-NP	O
1/25	1/25	CD	I-NP	O
chronic	chronic	JJ	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
HTN	HTN	NN	I-NP	O
alcoholic	alcoholic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
beta-thal	beta-thal	JJ	I-NP	O
trait	trait	NN	I-NP	O
alcoholic	alcoholic	JJ	I-NP	O
gastritis	gastritis	NN	I-NP	O
Hep	Hep	NN	I-NP	O
B/Hep	B/Hep	NN	I-NP	O
C	C	NN	I-NP	O
depression	depression	NN	I-NP	O
+	+	SYM	B-NP	O
PPD	PPD	NN	I-NP	O
narcotic	narcotic	JJ	I-NP	O
seeking	seek	VBG	I-NP	O
s/p	s/p	NN	I-NP	O
penectomy	penectomy	NN	I-NP	O
s/p	s/p	NN	I-NP	O
infected	infected	JJ	I-NP	O
penile	penile	JJ	I-NP	O
implant	implant	NN	I-NP	O
s/p	s/p	NN	I-NP	O
post-ant	post-ant	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
surgery	surgery	NN	I-NP	O
s/p	s/p	NN	I-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
unknown	unknown	JJ	B-NP	O
source	source	NN	I-NP	O
3/10	3/10	CD	I-NP	O
VT	VT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
long	long	JJ	I-NP	O
qt	qt	NN	I-NP	O
seizure	seizure	NN	I-NP	O
disorder	disorder	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
seizure	seizure	NN	I-NP	O
disorder	disorder	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
penile	penile	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/6/05	4/6/05	CD	I-NP	O
HD	HD	NN	I-NP	O
in	in	IN	B-PP	O
AM	AM	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Attending	Attend	VBG	B-VP	O
:	:	:	O	O
Lamkin	Lamkin	NNP	B-NP	O
,	,	,	O	O
Eliseo	Eliseo	NNP	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
54M	54M	NN	B-NP	O
with	with	IN	B-PP	O
ESRD+MMP	ESRD+MMP	NNP	B-NP	O
has	have	VBZ	B-VP	O
bleeding	bleed	VBG	I-VP	O
from	from	IN	B-PP	O
fistula	fistula	NN	B-NP	O
HPI	HPI	NN	I-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
ESRD	ESRD	NN	B-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
2003	2003	CD	I-NP	O
,	,	,	O	O
alcoholic	alcoholic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
PVD	PVD	NN	I-NP	O
,	,	,	O	O
long	long	JJ	B-NP	O
QTc	QTc	NNP	I-NP	O
syndrome	syndrome	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
recent	recent	JJ	I-NP	O
torsades	torsade	NNS	I-NP	O
-RRB-	-RRB-	VBP	B-VP	O
present	present	JJ	B-ADJP	O
with	with	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
from	from	IN	B-PP	O
AV	AV	NN	B-NP	O
fistula	fistula	NN	I-NP	O
.	.	.	O	O

Bleeding	Bleeding	NNP	B-NP	O
stopped	stop	VBD	B-VP	O
with	with	IN	B-PP	O
1ht	1ht	NN	B-NP	O
of	of	IN	B-PP	O
pressure	pressure	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
pt	pt	NN	B-NP	O
developed	develop	VBD	B-VP	O
pleuritic	pleuritic	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
subtle	subtle	JJ	B-NP	O
TW	TW	NNP	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
resolved	resolve	VBN	B-VP	O
after	after	IN	B-PP	O
lopressor	lopressor	NN	B-NP	O
.	.	.	O	O

Only	Only	RB	B-NP	O
other	other	JJ	I-NP	O
recent	recent	JJ	I-NP	O
complaint	complaint	NN	I-NP	O
is	be	VBZ	B-VP	O
sore	sore	JJ	B-NP	O
throat	throat	NN	I-NP	O
with	with	IN	B-PP	O
swallowing	swallow	VBG	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
PMHx	PMHx	NN	B-NP	O
:	:	:	O	O
DMI	DMI	NN	B-NP	O
,	,	,	O	O
ESRD	ESRD	NN	B-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
MI	MI	NN	I-NP	I-protein
and	and	CC	I-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
EtOH	EtOH	NN	B-NP	O
CM	CM	NNP	B-NP	O
,	,	,	O	O
PVD	PVD	NNP	B-NP	O
s/p	s/p	VBP	B-VP	O
L	L	NNP	B-NP	O
BKA	BKA	NN	I-NP	O
and	and	CC	I-NP	O
R	R	NN	I-NP	O
fem-tib	fem-tib	NN	I-NP	O
bypass	bypass	NN	I-NP	O
,	,	,	O	O
sz	sz	NN	B-NP	O
d/o	d/o	NN	I-NP	O
,	,	,	O	O
long	long	JJ	B-NP	O
QT	QT	NN	I-NP	O
s/p	s/p	NN	I-NP	O
recent	recent	JJ	I-NP	O
torsades	torsade	NNS	I-NP	O
episode	episode	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

NPH	NPH	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
MS	MS	NN	I-NP	B-protein
delta	delta	SYM	B-NP	I-protein
,	,	,	O	O
+	+	SYM	B-NP	O
PPD	PPD	NN	I-NP	O
hx	hx	NN	I-NP	O
,	,	,	O	O
Hep	Hep	NN	B-NP	B-protein
B	B	NNP	I-NP	I-protein
&	&	CC	I-NP	O
C	C	NNP	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
,	,	,	O	O
penisectomy	penisectomy	NN	B-NP	O
,	,	,	O	O
b-thal	b-thal	JJ	B-NP	O
trait	trait	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
Daily	Daily	JJ	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
Afebrile	Afebrile	NNP	B-NP	O
,	,	,	O	O
Alert	Alert	NNP	B-NP	O
,	,	,	O	O
oriented	orient	VBD	B-VP	O
x	x	NN	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
conversant	conversant	NN	B-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
CTA	CTA	NN	B-NP	B-protein
,	,	,	O	O
abd	abd	NN	B-NP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
NT	NT	NN	B-NP	O
with	with	IN	B-PP	O
+	+	SYM	O	O
BS	BS	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
fistula	fistula	NN	B-NP	O
patent	patent	NN	I-NP	O
-	-	HYPH	O	O
bandaged	bandage	VBN	B-VP	O
and	and	CC	O	O
not	not	RB	B-VP	O
oozing	ooze	VBG	I-VP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
EVENTS	EVENTS	NNS	I-NP	O
:	:	:	O	O
5/22/05	5/22/05	CD	B-NP	O
fistula	fistula	NN	I-NP	O
bleed	bleed	NN	I-NP	O
and	and	CC	O	O
CP	CP	NN	B-NP	B-protein
4/6/05	4/6/05	CD	I-NP	I-protein
HD	HD	NN	I-NP	I-protein
in	in	IN	B-PP	O
AM	AM	NN	B-NP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
1uPRBCs	1uPRBC	NNS	B-NP	O
in	in	IN	B-PP	O
PM	PM	NN	B-NP	O
.	.	.	O	O

11/29/05	11/29/05	CD	B-NP	O
received	receive	VBN	I-NP	O
1uPRBCs	1uPRBC	NNS	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Studies	Study	NNS	I-NP	O
:	:	:	O	O
Cath	Cath	NN	B-NP	B-protein
10/6	10/6	CD	I-NP	I-protein
showed	show	VBD	B-VP	O
complete	complete	JJ	B-NP	O
distal	distal	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
,	,	,	O	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
ramus	ramus	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
significant	significant	JJ	I-NP	O
dz	dz	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
:	:	:	O	O
LVH	LVH	NN	B-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
************	************	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54	54	CD	I-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
ESRD+MMP	ESRD+MMP	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
AVF	AVF	NN	I-NP	B-protein
.	.	.	O	O

PMH	PMH	NN	B-NP	O
sig	sig	NN	I-NP	O
for	for	IN	B-PP	O
brittle	brittle	JJ	B-NP	O
DMI	DMI	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
ESRD	ESRD	NN	B-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
2003	2003	CD	I-NP	O
,	,	,	O	O
alcoholic	alcoholic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
PVD	PVD	NN	I-NP	O
,	,	,	O	O
long	long	JJ	B-NP	O
QTc	QTc	NNP	I-NP	O
syndrome	syndrome	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
recent	recent	JJ	I-NP	O
torsades	torsade	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
also	also	RB	B-ADVP	O
c/o	c/o	VBP	B-VP	O
pleuritic	pleuritic	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
with	with	IN	B-PP	O
subtle	subtle	JJ	B-NP	O
TW	TW	NNP	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
recent	recent	JJ	B-NP	O
torsades	torsade	NNS	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

Repleted	Replete	VBN	B-NP	O
lytes	lyte	NNS	I-NP	O
prn	prn	VBP	B-VP	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
:	:	:	O	O
Echo	Echo	NNP	B-NP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
.	.	.	O	O

continue	continue	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
meds	med	NNS	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hydralazine	hydralazine	NN	B-NP	O
,	,	,	O	O
nitrite	nitrite	NN	B-NP	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
subtle	subtle	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
repeat	repeat	NN	I-NP	O
CP	CP	NN	I-NP	O
since	since	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
resolved	resolve	VBD	B-VP	O
somewhat	somewhat	RB	B-ADVP	O
by	by	IN	B-PP	O
end	end	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

cont	cont	VB	B-VP	O
ASA	ASA	NNP	B-NP	O
,	,	,	I-NP	O
BB	BB	NNP	I-NP	O
,	,	,	I-NP	O
statin	statin	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
restart	restart	VB	B-VP	O
plavix	plavix	NN	B-NP	O
as	as	IN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
hct	hct	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
34.6	34.6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
pt	pt	NN	I-NP	O
has	have	VBZ	B-VP	O
f/u	f/u	NN	B-NP	O
appt	appt	NN	I-NP	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
Dr	Dr	NNP	I-NP	O
Mitchel	Mitchel	NNP	I-NP	O
Lindquist	Lindquist	NNP	I-NP	O
9/30/5	9/30/5	CD	I-NP	O
at	at	IN	B-PP	O
4pm	4pm	NN	B-NP	O
,	,	,	O	O
051-469-9935	051-469-9935	CD	B-NP	O
,	,	,	O	O
As	As	IN	B-SBAR	O
Tonrham	Tonrham	NNP	B-NP	O
Eeli	Eeli	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
Ga	Ga	NNP	B-NP	O
Bilegarl	Bilegarl	NNP	I-NP	O
Proo	Proo	NNP	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
RENAL	RENAL	NNP	I-NP	O
:	:	:	O	O
ESRD	ESRD	NN	B-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
MWF	MWF	NN	I-NP	I-protein
,	,	,	O	O
last	last	JJ	B-NP	O
6/22/05	6/22/05	CD	I-NP	O
.	.	.	O	O

Fistula	Fistula	NN	B-NP	O
patent	patent	NN	I-NP	O
and	and	CC	O	O
working	work	VBG	B-VP	O
well	well	RB	B-ADVP	O
per	per	IN	B-PP	O
renal	renal	JJ	B-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

resume	resume	VB	B-VP	O
outpt	outpt	JJ	B-NP	O
HD	HD	NN	I-NP	O
schedule	schedule	NN	I-NP	O
MWF	MWF	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HEME	HEME	NN	I-NP	B-protein
:	:	:	O	O
Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
fistula	fistula	NN	B-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-VP	O
compounded	compound	VBN	I-VP	O
by	by	IN	B-PP	O
plavix	plavix	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

Hct	Hct	NN	B-NP	O
at	at	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
low	low	JJ	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
baseline	baseline	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Bleed	Bleed	NNP	B-NP	O
stopped	stop	VBD	B-VP	O
after	after	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

HD	HD	NN	B-NP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
in	in	IN	B-PP	O
AM	AM	NN	B-NP	O
4/6/05	4/6/05	CD	I-NP	O
,	,	,	O	O
but	but	CC	O	O
because	because	IN	B-SBAR	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
6	6	CD	I-NP	O
unit	unit	NN	I-NP	O
drop	drop	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
from	from	IN	B-PP	O
30	30	CD	B-NP	O
to	to	TO	I-NP	O
24	24	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
for	for	IN	B-PP	O
observation	observation	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
1	1	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
PRBCs	PRBC	NNS	B-NP	B-cell_type
.	.	.	O	O

pt	pt	NN	B-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
PRBCs	PRBC	NNS	B-NP	B-cell_type
2/22/05	2/22/05	CD	B-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
dicharged	dicharge	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
on	on	IN	B-PP	O
PM	PM	NN	B-NP	O
of	of	IN	B-PP	O
7/23/05	7/23/05	CD	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
guaiac	guaiac	NN	B-NP	O
+	+	SYM	B-NP	O
stool	stool	NN	I-NP	O
on	on	IN	B-PP	O
and	and	CC	I-PP	O
off	off	IN	I-PP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
never	never	RB	B-ADVP	O
frank	frank	NN	B-NP	O
melena	melena	NN	I-NP	O
or	or	CC	I-NP	O
BRBPR	BRBPR	NN	I-NP	B-protein
.	.	.	O	O

the	the	DT	B-NP	O
GI	GI	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
informally	informally	RB	I-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
as	as	RB	B-ADVP	O
long	long	JJ	I-ADVP	O
as	as	IN	B-SBAR	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
an	an	DT	B-NP	O
inpatient	inpatient	JJ	I-NP	O
issue	issue	NN	I-NP	O
to	to	TO	B-VP	O
urgently	urgently	RB	I-VP	O
pursue	pursue	VB	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
Hct	Hct	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
34.6	34.6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
was	be	VBD	B-VP	O
around	around	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
team	team	NN	I-NP	O
agreed	agree	VBD	B-VP	O
with	with	IN	B-PP	O
GI	GI	NN	B-NP	O
's	's	POS	B-NP	O
assessment	assessment	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
pt	pt	NN	I-NP	O
has	have	VBZ	B-VP	O
outpt	outpt	JJ	B-NP	O
GI	GI	NN	I-NP	O
appt	appt	NN	I-NP	O
on	on	IN	B-PP	O
6/20/05	6/20/05	CD	B-NP	O
at	at	IN	B-PP	O
10AM	10AM	NN	B-NP	O
with	with	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Picozzi	Picozzi	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
059-631-4196	059-631-4196	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
NEURO	NEURO	NN	I-NP	O
:	:	:	O	O
Sz	Sz	NN	B-NP	O
d/o	d/o	NN	I-NP	O
on	on	IN	B-PP	O
Keppra	Keppra	NNP	B-NP	O
.	.	.	O	O

Mental	Mental	JJ	B-NP	O
status	status	NN	I-NP	O
improved	improve	VBD	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
admission	admission	NN	I-NP	O
description	description	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
&	&	CC	I-NP	B-DNA
O	O	NNP	I-NP	I-DNA
x	x	NNP	I-NP	I-DNA
3	3	CD	I-NP	I-DNA
,	,	,	O	O
responds	respond	VBZ	B-VP	O
appropriately	appropriately	RB	B-ADVP	O
to	to	TO	B-PP	O
questions	question	NNS	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
sore	sore	JJ	B-NP	O
throat	throat	NN	I-NP	O
with	with	IN	B-PP	O
?	?	.	O	O

esophagitis	esophagitis	NN	B-NP	O
,	,	,	I-NP	O
nystatin	nystatin	NN	I-NP	O
S	S	NNP	I-NP	O
&	&	CC	I-NP	O
S	S	NNP	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ENDO	ENDO	NNP	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
with	with	IN	B-PP	O
hypo/hyperglycemic	hypo/hyperglycemic	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
.	.	.	O	O

Prev	Prev	NN	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
endocrine	endocrine	NN	B-NP	O
for	for	IN	B-PP	O
labile	labile	JJ	B-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
home	home	NN	B-NP	O
lantus	lantus	NN	I-NP	O
+	+	SYM	B-NP	O
3	3	CD	I-NP	O
units	unit	NNS	I-NP	O
qAC	qAC	NN	I-NP	O
+	+	SYM	O	O
SS	SS	NN	B-NP	O
novolog	novolog	NN	I-NP	O
.	.	.	O	O

increased	increase	VBN	B-NP	O
home	home	NN	I-NP	O
lantus	lantus	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
15u	15u	CD	B-NP	O
qHS	qHS	NN	I-NP	O
but	but	CC	I-NP	O
am	am	NN	I-NP	O
sugar	sugar	NN	I-NP	O
26	26	CD	I-NP	O
on	on	IN	B-PP	O
8/28	8/28	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
low	low	JJ	B-NP	O
sugars	sugar	NNS	I-NP	O
again	again	RB	B-ADVP	O
on	on	IN	B-PP	O
AM	AM	NN	B-NP	B-DNA
2/30/05	2/30/05	CD	I-NP	I-DNA
,	,	,	O	O
so	so	RB	B-ADVP	O
will	will	MD	B-VP	O
send	send	VB	I-VP	O
out	out	RP	B-PRT	O
on	on	IN	B-PP	O
lantus	lantus	NN	B-NP	O
6	6	CD	B-NP	O
qhs	qh	NNS	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
closely	closely	RB	I-VP	O
monitor	monitor	VB	I-VP	O
bs	b	NNS	B-NP	O
and	and	CC	O	O
titrate	titrate	VB	B-VP	O
lantus/novolog	lantus/novolog	NN	B-NP	O
SS	SS	NN	I-NP	O
qAC	qAC	NN	I-NP	O
appropriately	appropriately	RB	B-ADVP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
will	will	MD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
require	require	VBP	B-VP	O
a	a	DT	B-NP	O
bedtime	bedtime	NN	I-NP	O
snack	snack	NN	I-NP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
his	his	PRP$	B-NP	O
early	early	JJ	I-NP	O
morning	morning	NN	I-NP	O
hypoglycemic	hypoglycemic	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
f/u	f/u	NN	I-NP	O
appt	appt	NN	I-NP	O
with	with	IN	B-PP	O
endocrine	endocrine	JJ	B-NP	O
clinic	clinic	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
837-578-9683	837-578-9683	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
9/29/05	9/29/05	CD	I-NP	O
at	at	IN	B-PP	O
11AM	11AM	NN	B-NP	O
,	,	,	O	O
Queriedu	Queriedu	NNP	B-NP	O
Tempe	Tempe	NNP	I-NP	O
No	No	NNP	I-NP	O
Hamgent	Hamgent	NNP	I-NP	O
Morma	Morma	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
Te	Te	NNP	B-NP	O
West	West	NNP	I-NP	O
Ton	Ton	NNP	I-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FEN	FEN	NNP	I-NP	O
:	:	:	O	O
Repleted	Replete	VBN	B-NP	O
lytes	lyte	NNS	I-NP	O
,	,	,	O	O
esp	esp	NN	B-NP	O
Mg	Mg	NN	I-NP	O
given	give	VBN	B-VP	O
recent	recent	JJ	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
torsades	torsade	NNS	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
prior	prior	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
risk	risk	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
POs	PO	NNS	B-NP	B-protein
well	well	RB	B-ADVP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Ppx	Ppx	NN	I-NP	O
:	:	:	O	O
PPI	PPI	NN	B-NP	B-protein
,	,	,	O	O
SC	SC	NN	B-NP	O
heparin	heparin	NN	I-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dispo	dispo	NN	I-NP	O
:	:	:	O	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
when	when	WRB	B-ADVP	O
Hct	Hct	NN	B-NP	O
stable	stable	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
d/c	d/c	NN	I-NP	O
Hct	Hct	NN	I-NP	O
at	at	IN	B-PP	O
34.6	34.6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
2/30/05	2/30/05	CD	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
CODE	CODE	NN	B-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-INTJ	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
clinic	clinic	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
appointments	appointment	NNS	I-NP	O
on	on	IN	B-PP	O
monday	monday	NN	B-NP	O
6/22/05	6/22/05	CD	I-NP	O
.	.	.	O	O

come	come	VB	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
fistula	fistula	NN	I-NP	O
starts	start	VBZ	B-VP	O
to	to	TO	I-VP	O
bleed	bleed	VB	I-VP	O
again	again	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
follow	follow	VB	B-VP	O
serial	serial	JJ	B-NP	O
Hcts	Hct	NNS	I-NP	O
.	.	.	O	O

monitor	monitor	NN	B-NP	O
AVF	AVF	NN	I-NP	O
for	for	IN	B-PP	O
future	future	JJ	B-NP	O
bleeds	bleed	NNS	I-NP	O
.	.	.	O	O

please	please	VB	B-VP	O
closely	closely	RB	B-NP	O
monitor	monitor	JJ	I-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
sugar	sugar	NN	I-NP	O
levels	level	NNS	I-NP	O
--	--	:	O	O
he	he	PRP	B-NP	O
needs	need	VBZ	B-VP	O
a	a	DT	B-NP	O
bedtime	bedtime	NN	I-NP	O
snack	snack	NN	I-NP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
bottoming	bottom	VBG	I-VP	O
out	out	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
mornings	morning	NNS	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
f/u	f/u	NN	B-NP	O
appointments	appointment	NNS	I-NP	O
for	for	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
GI	GI	NN	B-NP	O
--	--	:	O	O
please	please	VB	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
makes	make	VBZ	B-VP	O
it	it	PRP	B-NP	O
or	or	CC	O	O
they	they	PRP	B-NP	O
will	will	MD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
drop	drop	VB	B-VP	O
him	him	PRP	B-NP	O
from	from	IN	B-PP	O
their	their	PRP$	B-NP	O
pt	pt	NN	I-NP	O
lists	list	NNS	I-NP	O
-LRB-	-LRB-	SYM	O	O
2/2	2/2	CD	B-NP	O
multiple	multiple	JJ	I-NP	O
no-shows	no-show	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

thanks	thank	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BLEE	BLEE	NNP	B-NP	O
,	,	,	O	O
RICHIE	RICHIE	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IK60	IK60	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/21/05	10/21/05	CD	I-NP	O
@	@	SYM	B-NP	O
04	04	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

